Skip to content
DeepViews

Agilent Technologies Inc. (A) — Analysis Summary

Agilent Technologies Inc. (A) has a market cap of $44.46B with year-over-year revenue growth of +6.7%. Net margin stands at 18.8%. The stock trades at a P/E ratio of 31.4.

Key Takeaways

  • Revenue changed +6.7% year-over-year
  • Net margin of 18.8%
  • P/E ratio of 31.4

Compared to other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector, A posted revenue growth of +6.7% and trades at a P/E of 31.4.

[XNYS]

Agilent Technologies Inc. (A)

$153.84

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$44.46B
Enterprise Value
$46.01B
P/E Ratio
31.4
Div Yield
0.66%
EV/EBITDA
25.1
Company Profile
About
About Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Sector

LABORATORY ANALYTICAL INSTRUMENTS

Employees

18,100

Headquarters

SANTA CLARA, CA

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
59
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$-202.00M
Total Debt$3355.00M
Debt-to-EquityN/A
Cash & Equivalents$1807.00M

Cash Flow

Operating Cash Flow$1452.00M
Free Cash Flow$1087.00M
FCF Margin15.03%
P/FCF Ratio40.90
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$1.02

Dividend Yield

0.66%

Quarterly
Last Ex-Date: 2026-06-30

Dividend History

2026-06-30
CD$0.2550
2026-03-31
CD$0.2550
2026-01-06
CD$0.2550
2025-09-30
CD$0.2480
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.